Purpose: The stability of a triamcinolone acetonide mouthwash and its efficacy in treating oral lichen planus are described. Results: The mouthwash had a satisfactory shelf life and was well ...

Mayo Clinic researchers have identified a targeted therapy that could bring relief to people living with lichen planus ... Baricitinib is an oral JAK 1/2 inhibitor that interrupts the signaling ...

Lipella Pharmaceuticals shares were up 37% to $4.18 after the company said it saw positive topline results from its Phase 2a dose-ranging trial examining LP-310, a liposomal-tacrolimus oral rinse ...

The results of this preliminary study suggest that this mouthwash was a safe and effective therapy for reducing the signs and symptoms of oral lichen planus. However, the therapeutic effectiveness ...